Drug Profile
Protein tyrosine phosphatase 1b inhibitor - Serono
Alternative Names: PTP1b inhibitorLatest Information Update: 22 May 2006
Price :
$50
*
At a glance
- Originator Merck Serono
- Class
- Mechanism of Action Protein-tyrosine-phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Obesity
Most Recent Events
- 22 May 2006 No development reported - Phase-I for Diabetes mellitus in Switzerland (unspecified route)
- 22 May 2006 No development reported - Phase-I for Obesity in Switzerland (unspecified route)
- 17 May 2005 Phase-I clinical trials in Diabetes mellitus in Switzerland (unspecified route)